|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hussain SP and Harris CC: Molecular
epidemiology of human cancer. Recent Results Cancer Res. 154:22–36.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piyathilake CJ, Frost AR, Bell WC,
Oelschlager D, Weiss H, Johanning GL, Niveleau A, Heimburger DC and
Grizzle WE: Altered global methylation of DNA: An epigenetic
difference in susceptibility for lung cancer is associated with its
progression. Hum Pathol. 32:856–862. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soria JC, Rodriguez M, Liu DD, Lee JJ,
Hong WK and Mao L: Aberrant promoter methylation of multiple genes
in bronchial brush samples from former cigarette smokers. Cancer
Res. 62:351–355. 2002.PubMed/NCBI
|
|
7
|
Wistuba II, Mao L and Gazdar AF: Smoking
molecular damage in bronchial epithelium. Oncogene. 21:7298–7306.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin Y, Xu P, Liu X, Zhang C, Tan C, Chen
C, Sun X and Xu Y: Cigarette smoking, BPDE-DNA adducts, and
aberrant promoter methylations of tumor suppressor genes (TSGs) in
NSCLC from Chinese population. Cancer Invest. 34:173–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tessema M, Yingling CM, Liu Y, Tellez CS,
Van Neste L, Baylin SS and Belinsky SA: Genome-wide unmasking of
epigenetically silenced genes in lung adenocarcinoma from smokers
and never smokers. Carcinogenesis. 35:1248–1257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sundar IK, Nevid MZ, Friedman AE and
Rahman I: Cigarette smoke induces distinct histone modifications in
lung cells: Implications for the pathogenesis of COPD and lung
cancer. J Proteome Res. 13:982–996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Søes S, Daugaard IL, Sørensen BS, Carus A,
Mattheisen M, Alsner J, Overgaard J, Hager H, Hansen LL and
Kristensen LS: Hypomethylation and increased expression of the
putative oncogene ELMO3 are associated with lung cancer development
and metastases formation. Oncoscience. 1:367–374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bjaanaes MM, Fleischer T, Halvorsen AR,
Daunay A, Busato F, Solberg S, Jørgensen L, Kure E, Edvardsen H,
Børresen-Dale AL, et al: Genome-wide DNA methylation analyses in
lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation
status, gene expression and prognosis. Mol Oncol. 10:330–343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wiles ET and Selker EU: H3K27 methylation:
A promiscuous repressive chromatin mark. Curr Opin Genet Dev.
43:31–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Q, Liu Y, Zheng X, Zhu Q, Shen Z, Wang
H, He H, Lin N, Jiang H, Yu L and Zeng S: Histone H3 lysine 4
Trimethylation, lysine 27 trimethylation, and lysine 27 acetylation
contribute to the transcriptional repression of solute carrier
family 47 member 2 in renal cell carcinoma. Drug Metab Dispos.
45:109–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang X, Li F, Konze KD, Meslamani J, Ma A,
Brown PJ, Zhou MM, Arrowsmith CH, Kaniskan HÜ, Vedadi M and Jin J:
Structure-activity relationship studies for enhancer of zeste
homologue 2 (EZH2) and enhancer of zeste homologue 1 (EZH1)
inhibitors. J Med Chem. 59:7617–7633. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Xu Z, Zhong L, Wang H, Jiang S,
Long Q, Xu J and Guo J: Enhancer of zeste homolog 2 (EZH2) promotes
tumour cell migration and invasion via epigenetic repression of
E-cadherin in renal cell carcinoma. BJU Int. 117:351–362. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Song N, Matsumoto K, Nanashima A,
Nagayasu T, Hayashi T, Ying M, Endo D, Wu Z and Koji T: High
expression of trimethylated histone H3 at lysine 27 predicts better
prognosis in non-small cell lung cancer. Int J Oncol. 43:1467–1480.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen VW, Ruiz BA, Hsieh MC, Wu XC, Ries LA
and Lewis DR: Analysis of stage and clinical/prognostic factors for
lung cancer from SEER registries: AJCC staging and collaborative
stage data collection system. Cancer. 120 Suppl 23:S3781–S3792.
2014. View Article : Google Scholar
|
|
19
|
Taira K, Hiroyasu S, Shiraishi M, Muto Y
and Koji T: Role of the Fas system in liver regeneration after a
partial hepatectomy in rats. Eur Surg Res. 33:334–341. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fujiwara K, Fujimoto N, Tabata M, Nishii
K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H and
Tanimoto M: Identification of epigenetic aberrant promoter
methylation in serum DNA is useful for early detection of lung
cancer. Clin Cancer Res. 11:1219–1225. 2005.PubMed/NCBI
|
|
21
|
Shirendeb U, Hishikawa Y, Moriyama S, Win
N, Thu MM, Mar KS, Khatanbaatar G, Masuzaki H and Koji T: Human
papillomavirus infection and its possible correlation with p63
expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta
Histochem Cytochem. 42:181–190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song N, Liu J, An S, Nishino T, Hishikawa
Y and Koji T: Immunohistochemical analysis of histone H3
modifications in germ cells during mouse spermatogenesis. Acta
Histochem Cytochem. 44:183–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adams JC: Heavy metal intensification of
DAB-based HRP reaction product. J Histochem Cytochem. 29:7751981.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ellinger J, Kahl P, von der Gathen J,
Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von
Ruecker A, Müller SC and Rogenhofer S: Global histone H3K27
methylation levels are different in localized and metastatic
prostate cancer. Cancer Invest. 30:92–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gavrieli Y, Sherman Y and Ben-Sasson SA:
Identification of programmed cell death in situ via specific
labeling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koji T, Kondo S, Hishikawa Y, An S and
Sato Y: In situ detection of methylated DNA by histo
endonuclease-linked detection of methylated DNA sites: A new
principle of analysis of DNA methylation. Histochem Cell Biol.
130:917–925. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ross JP, Rand KN and Molloy PL:
Hypomethylation of repeated DNA sequences in cancer. Epigenomics.
2:245–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Digel W and Lübbert M: DNA methylation
disturbances as novel therapeutic target in lung cancer:
Preclinical and clinical results. Crit Rev Oncol Hematol. 55:1–11.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Usemann J, Ernst T, Schäfer V, Lehmberg K
and Seeger K: EZH2 mutation in an adolescent with Weaver syndrome
developing acute myeloid leukemia and secondary
hemophagocyticlymphohistiocytosis. Am J Med Genet A. 170A:1–1277.
2016.
|
|
31
|
Tiffen JC, Gunatilake D, Gallagher SJ,
Gowrishankar K, Heinemann A, Cullinane C, Dutton-Regester K, Pupo
GM, Strbenac D, Yang JY, et al: Targeting activating mutations of
EZH2 leads to potent cell growth inhibition in human melanoma by
derepression of tumor suppressor genes. Oncotarget. 6:27023–27036.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bosselut R: Pleiotropic functions of
H3K27Me3 demethylases in immune cell differentiation. Trends
Immunol. 37:102–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Z, Gao J, Popovic R, Wolniak K,
Parimi V, Winter JN, Licht JD and Chen YH: Strong expression of
EZH2 and accumulation of trimethylated H3K27 in diffuse large
B-cell lymphoma independent of cell of origin and EZH2 codon 641
mutation. Leuk Lymphoma. 56:2895–2901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vick AD and Burris HH: Epigenetics and
health disparities. Curr Epidemiol Rep. 4:31–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Valeri L, Reese SL, Zhao S, Page CM,
Nystad W, Coull BA and London SJ: Misclassified exposure in
epigenetic mediation analyses. Does DNA methylation mediate effects
of smoking on birthweight? Epigenomics. 9:253–265. 2017.PubMed/NCBI
|
|
36
|
Tehranifar P, Wu HC, McDonald JA, Jasmine
F, Santella RM, Gurvich I, Flom JD and Terry MB: Maternal cigarette
smoking during pregnancy and offspring DNA methylation in midlife.
Epigenetics. May 11–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeshima H, Wakabayashi M, Hattori N,
Yamashita S and Ushijima T: Identification of coexistence of DNA
methylation and H3K27me3 specifically in cancer cells as a
promising target for epigenetic therapy. Carcinogenesis.
36:192–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
